SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India informs about incorporation WOS

27 Nov 2025 Evaluate

Granules India has informed that Granules Pharmaceuticals, Inc., a Wholly Owned foreign subsidiary of the Company, has incorporated a Wholly Owned Subsidiary (WOS), namely ‘Granules Pharmaceuticals Canada, Inc.’ in Canada on November 26, 2025. In terms of the Listing Regulations read with the SEBI Circular No SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023 on Disclosure of material events/information, we are furnishing herewith the details in the enclosed Annexure.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×